Population pharmacokinetic model
MALIGNANCIES
The PopPK analysis included plasma cabozantinib concentration–time data from CheckMate 9ER and 10 studies from a previously developed integrated PopPK model that characterized cabozantinib concentration data from healthy subjects and patients with various types of malignancies [The analytical data preparation has been previously described [